Primary thyroid lymphoma: A review of recent developments in diagnosis and histology-driven treatment

Current Opinion in Oncology

Volumn 22, Issue 1, 2010, Pages 17-22

  Graff Baker, Amanda ^a   Sosa, Julie Ann ^a   Roman, Sanziana A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Predictors of survival; Primary thyroid lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG EFFECT; FOLLICULAR LYMPHOMA; FOOD AND DRUG ADMINISTRATION; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOSTIMULATION; LARGE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PATHOGENESIS; POPULATION RESEARCH; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SOMATIC HYPERMUTATION; THYROID GLAND; THYROID LYMPHOMA;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; THYROID NEOPLASMS;

EID: 73849149190     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e3283330848     Document Type: Review

References (30)

1. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999; 26:316-323.
2. Green LD, Mack L, Pasieka JL. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol 2006; 94:725-736.
3. Fujita A, Tomita N, Fujita H, et al. Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan. Med Oncol 2009; 26:49-54.
4. Graff-Baker A, Roman SA, Thomas DC. Prognosis of primary thyroid lymphoma: demographic, clinical and pathologic predictors of survival in 1408 cases. Surgery (in press).
5. Derringer GA, Thompson LD, Frommelt RA, et al. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000; 24:623-639.
6. Ha CS, Shadle KM, Medeiros LJ, et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 2001; 91:629-635.
7. Holm LE, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312:601-604.
8. Niitsu N, Okamoto M, Nakamura N, et al. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma. Ann Oncol 2007; 18:1203-1208. (Pubitemid 47244367)
9. Rossi D. Thyroid lymphoma: beyond antigen stimulation. Leuk Res 2009; 33:607-609.
10. Au WY, Fung A, Ma ES, et al. HLA associations, microsatellite instability and epigenetic changes in thyroid lymphoma in Chinese. Leuk Lymphoma 2007; 48:531-534.
11. Longo D. Malignancies of lymphoid cells. In: Harrison's principles of internal medicine, 17th ed. New York: McGraw-Hill Companies, Inc; 2008. p. 691.
12. Hwang YC, Kim TY, Kim WB, et al. Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J 2009; 56:399-405.
13. Rawal A, Finn WG, Schnitzer B, Valdez R. Site-specific morphologic differences in extranodal marginal zone B-cell lymphomas. Arch Pathol Lab Med 2007; 131:1673-1678.
14. Suh C, Huh J, Roh JL. Extranodal marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence. Oral Oncol 2008; 44:949-955.
15. Kojima M, Nakamura N, Shimizu K, et al. MALT type lymphoma demonstrating prominent plasma cell differentiation resembling fibrous variant of Hashimoto's thyroiditis: a three case report. Pathol Oncol Res 2009; 15:285-289.
16. Bacon CM, Diss TC, Ye H, et al. Follicular lymphoma of the thyroid gland. Am J Surg Pathol 2009; 33:22-34.
17. Yang H, Li J, Shen T. Primary T-cell lymphoma of the thyroid: case report and review of the literature. Med Oncol 2008; 25:462-466.
18. Moshynska OV, Saxena A. Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol 2008; 61:438-444.
19. Takakuwa T, Miyauchi A, Aozasa K. Aberrant somatic hypermutations in thyroid lymphomas. Leuk Res 2009; 33:649-654.
20. Takano T, Asahi S, Matsuzuka F, et al. Aspiration biopsy-nucleic acid diagnosis of thyroid malignant lymphoma by vectorette PCR: experience of eight cases. Leuk Res 2008; 32:151-154.
21. Kwak JY, Kim EK, Ko KH, et al. Primary thyroid lymphoma: role of ultrasoundguided needle biopsy. J Ultrasound Med 2007; 26:1761-1765.
22. Velasquez WS, Jagannath S, Tucker SL, et al. Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data. Blood 1989; 74:551-557.
23. Lee CJ, Hsu CH, Tai CJ, Lin SE. FDG-PET for a thyroid MALT lymphoma. Acta Oncol 2008; 47:1165-1167.
24. Basu S, Li G, Bural G, Alavi A. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Acta Radiol 2009; 50:201-204.
25. DiBiase SJ, Grigsby PW, Guo C, et al. Outcome analysis for stage IE and IIE thyroid lymphoma. Am J Clin Oncol 2004; 27:178-184.
26. Maloney DG, Liles TM, Czerwinski DK, et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994; 84:2457-2466.
27. Ganguly S, Patel V. R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature. J Hematol Oncol 2009; 2:14.
28. Dai CW, Zhang GS, Pei MF, Shen JK. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy. Ann Hematol 2009; 88:701-702.
29. Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008; 9:105-116.
30. Lee J, Won JH, Kim HC, Soh EY. Emergency dilation by self-expandable tracheal stent for upper airway obstruction in a patient with a giant primary thyroid lymphoma. Thyroid 2009; 19:193-195.